Open | 6.41 |
Previous Close | 6.43 |
Day Range | 5.82 - 6.41 |
52-Week Range | 5.49 - 16.63 |
All-Time High | 17.02 |
Avg. Volume (50-day) | 218,884.81 |
EPS (TTM) | -3.02 |
Next Earnings Date | 2025-08-11 |
Last Earnings Date | 2025-03-24 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | -2.13 |
PEG Ratio | - |
Price to Book | 9.69 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 63.383 M |
Share Float (%) | 55.13 M |
% Held by Institutions | 35.67 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 6.86 (-8.89%) |
+/- SMA(50) | 6.78 (-7.82%) |
+/- SMA(200) | 9.62 (-35.03%) |
5-Day Perf. | -15.2% |
1-Month Perf. | -18.62% |
3-Month Perf. | -14.62% |
6-Month Perf. | -45.75% |
YTD Perf. | -14.62% |
1-Year Perf. | -56.29% |
RSI(14) | 40.22 |
ATR(14) | 0.6 |
ADX(14) | 18.21 |
Beta (5Y) | 0.30 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.
ABVX has triggered the following predefined scans:
Hammer |
Parabolic SAR Sell Signals |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.